Patient description and tumor sample characteristics

SampleSexAgeTumor typeLocationSample Concentration (μg/μl)Sample volume (μl)Ki-67 indexp53Underlying disease
N1M66Normal brain (human adult)Whole brain4.47150
N2M57Normal brain (human adult)Whole brain4.32150
N3M82Normal brain (human adult)Whole brain4.89150
Group 1Meningioma, WHO grade I
1M61Meningioma, meningothelialParasagittal, right28.62110<1%(−)Alcohol, smoking
2F64Meningioma, fibrousFalx, right29.132001~2%(−)(−)
3F64Meningioma, meningothelialCPA, right23.011001%(−)(−)
4F56Meningioma, transitionalConvexity, right41.67600<1%15%HTN, DM
5F74Meningioma, transitionalFalx, both30.99400<1%30%(−)
Group 2Pituitary adenoma
6F51Pituitary adenomaPituitary gland19.47100<1%1%(−)
7F42Pituitary adenoma, ACTH producingPituitary gland17.9490<1%1%Cushing disease
8M51Pituitary adenomaPituitary gland20.19110<1%(−)DM
9M38Pituitary adenomaPituitary gland20.31501%1%(−)
10F53Pituitary adenomaPituitary gland18.0090<1%5%(−)

WHO, world health organization; CPA, cerebellopontine angle; HTN, hypertension; DM, diabetes mellitus; ACTH, adrenocorticotropic hormone.

Exp Neurobiol 2019;28:628~641 https://doi.org/10.5607/en.2019.28.5.628
© Exp Neurobiol